Outbreak Surveillance and Infection Prevention require accurate typing and characterization of bacterial isolates. Sequence your isolates with the pathogenomics- and AMR-experts at Ares Genetics and rely on the validated, AI powered ARESiss platform for accurate, comprehensive, and epidemiologically relevant data from microbial isolates.
The ARESiss platform has been validated end-to-end using CLIA-grade processes to ensure accurate and reproducible isolate sequencing results.1
For research use only and not for diagnostics purposes.
ARESdb is a comprehensive collection of resistance-associated genes and genetic markers for AMR. ARESdb includes known biomarkers and novel ones identified by our proprietary AI discovery platform. Additionally, ARESdb holds an industry-leading set of curated antibiotic susceptibility profiles and associated genomic information, enabling predictive AST.2,3
ARESai aims to set the Industry Standard for AI powered Infectious disease testing inaccordance with FDA guidelines.4,5 Ares data analysis enables pathogen identification and antibiotic resistance detection with superior accuracy.6,7 The award-winning team of Ares data scientists has demonstrated superior accuracy in independent studies, including the first multi-center evaluation of NGS-based predictive AST.6,8
AREScloud is a web-based, user-friendly portal to Isolate Reports and an interface enabling decentralized NGS-based Isolate Analysis for reference labs and medical centers.
An industry leading database and AI powered bioinformatics platform convert isolate genome data into epidemiologically actionable information.